Metropolitan Life Insurance Company (MetLife)’s Arcellx ACLX Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ACLX Stock Details ACLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,107	Closed	-$147K	–	34
2024 Q1	$147K	Sell	2,107 -189	-8%	-$12K	0.01%	852
2023 Q4	$127K	Hold	2,296	–	–	0.01%	957
2023 Q3	$82.4K	Buy	2,296 +204	+10%	+$7.03K	﹤0.01%	1120
2023 Q2	$66.1K	Buy	2,092 +375	+22%	+$14.3K	﹤0.01%	1263
2023 Q1	$52.9K	Sell	1,717 -193	-10%	-$5.86K	﹤0.01%	1358
2022 Q4	$59.2K	Hold	1,910	–	–	﹤0.01%	1362
2022 Q3	$35.9K	Buy	+1,910	New	+$36.5K	﹤0.01%	1687

Other funds holding ACLX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s ACLX Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Arcellx (ACLX) in Q2 2024, closing a stake of 2,107 shares — an estimated $147K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ACLX in Q3 2022 and held it in 7 quarters. The position peaked at $147K in Q1 2024. 167 funds tracked by Wall St. Rank hold ACLX as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Arcellx position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 2,107 Arcellx shares in Q2 2024, an estimated $147K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Arcellx in Q3 2022 and held it in 7 quarters.
Metropolitan Life Insurance Company (MetLife)'s Arcellx position peaked at $147K in Q1 2024.
167 funds tracked by Wall St. Rank held Arcellx as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.